Clinical trial

Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer

NCT06775678

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

RADIATION · Unmapped registry intervention Spatially Fractionated Radiation Therapy Combined With Low-dose Radiotherapy Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Conventional fractionated radiotherapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-10-01

PhasePHASE2

Conditions

Lung Cancersunresolved

Radiation Treatment for Tumorsunresolved

Interventions

Spatially Fractionated Radiation Therapy Combined With Low-dose RadiotherapyRADIATION

Conventional fractionated radiotherapyRADIATION

Sponsors & collaborators

Tianjin Medical University Cancer Institute and Hospitallead sponsor

Mapped research locations

TianjinTianjin Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06775678 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.